D. Ryba

Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride.

M. B. Rosenbaum, M. Elizari, P. Chiale, 1974, The American journal of cardiology.

Modifications of Sarcoplasmic Reticulum Function Prevent Progression of Sarcomere-Linked Hypertrophic Cardiomyopathy Despite a Persistent Increase in Myofilament Calcium Response

Shamim A. K. Chowdhury, E. Kranias, B. Wolska, 2020, Frontiers in Physiology.

Long-Term Biased &bgr;-Arrestin Signaling Improves Cardiac Structure and Function in Dilated Cardiomyopathy

B. Russell, B. Wolska, C. Cowan, 2017, Circulation.

Sphingosine-1-Phosphate Receptor Modulator, FTY720, Improves Diastolic Dysfunction and Partially Reverses Atrial Remodeling in a Tm-E180G Mouse Model Linked to Hypertrophic Cardiomyopathy.

Shamim A. K. Chowdhury, C. Liew, B. Wolska, 2019, Circulation. Heart failure.

Cardiac myosin light chain phosphorylation and inotropic effects of a biased ligand, TRV120023, in a dilated cardiomyopathy model.

J. Violin, B. Wolska, C. Cowan, 2015, Cardiovascular research.

Omecamtiv Mecarbil, a Cardiac Myosin Activator, Increases Ca2+ Sensitivity in Myofilaments With a Dilated Cardiomyopathy Mutant Tropomyosin E54K

B. Wolska, R. Solaro, D. Ryba, 2015, Journal of cardiovascular pharmacology.

A Critical Role for Estrogen-Related Receptor Signaling in Cardiac Maturation

Rick B. Vega, Kyoung-Jae Won, K. Musunuru, 2020, Circulation research.

Control of the tachyarrhythmias associated with the Wolff-Parkinson-White by amiodarone

M. Elizari, P. Chiale, D. Ryba, 1974 .

N-acetylcysteine reverses diastolic dysfunction and hypertrophy in familial hypertrophic cardiomyopathy.

B. Wolska, R. Solaro, D. Ryba, 2015, American journal of physiology. Heart and circulatory physiology.